NECA Team’s Advocacy Efforts Extend to 13 Industry Boards and working groups for Neuroendocrine Cancer Patients

Recognising the critical importance of collaboration and advocacy behind the scenes, the NECA Team embraces the opportunity to contribute to shaping the landscape for Neuroendocrine Cancer patients.

By sitting on this group of diverse boards, working and study groups, the team ensures a comprehensive and informed approach to addressing the unique challenges faced by individuals diagnosed with neuroendocrine cancer.

  • Cancer Nurses Association of Australia (CNSA) – Vice President, Board of Directors
  • Coalition of National Nursing Organisations (CoNNMO) – Council
  • Alliance & Partnerships for Patient Innovation & Solutions (APPIS) – Council, Expert Advisory Panel
  • International Neuroendocrine Cancer Alliance (INCA) – Board of Directors, Chair of Research Committee
  • Australian Cancer Nurse Navigation Program – Expert Advisory Group, Telehealth Nurse Working Group
  • NSW Health Consumers  – Consumer Organisations Taskforce
  • Cancer Organisations Collaboration – representative Non Government organisations
  • The Australasian Association of Nuclear Medicine Specialists (AANMS) Theranostics Meeting
  • Commonwealth Neuroendocrine Tumour research collaborative (CommNETs) Working Group
  • AUSNET Study Group
  • North Foundation Development Committee
  • NET Nurse Special Interest Group

Through these collaborative efforts, the NECA Team aims to amplify the voices of patients and advocate for improved resources, research, and support networks.

The NECA Team extends gratitude to the boards and their members for the opportunity to contribute to the collective mission of enhancing the lives of Neuroendocrine Cancer patients.

As the advocacy journey continues, the NECA Team remains steadfast in its commitment to making a meaningful impact and fostering positive change within the Neuroendocrine Cancer community.

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

ANZSNM 56th Annual Conference – Canberra (ACT), Australia

Nurses Workshop, Sunday, 17 May 2026

NECA Joins Boehringer Ingelheim Panel Discussion on Clinical Trials and Patient Access

Healing NETS Summit

Tax Appeal

Screenshot 2026-05-20 at 2.12.07 PM

Help 31,000+ neuroendocrine cancer patients get the specialised care they deserve.

Every dollar raised is fully tax deductible and helps fund much needed advocacy efforts and patient support.